Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1998
10/20/1998US5824784 Genetic engineering with polypeptides and proteins
10/20/1998US5824782 Immunoconjugates II
10/20/1998US5824776 Cell-targeted lytic pore-forming agents
10/20/1998US5824774 Chimeric isoprenoid synthases and uses thereof
10/20/1998US5824685 Vision defects and gene expression
10/20/1998US5824681 Immunomodulating effect
10/20/1998US5824674 Brefeldin A derivatives and their utility in the treatment of cancer
10/20/1998US5824652 Heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
10/20/1998US5824640 Substances of polypeptide nature useful in human therapy
10/20/1998US5824636 Protein with amino acid sequence with antitumor effects
10/20/1998US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery
10/20/1998US5824508 Dna and amino acid sequences, vectors and host cells
10/20/1998US5824504 Polynucleotides
10/20/1998US5824490 Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
10/20/1998US5824305 Bromelain protease of amino acid sequences as bactericides,anticarcinogenic agents, antiinflammatory agents or atherosclerosis
10/20/1998US5824304 Peripheralization of hematopoietic stem cells
10/20/1998US5824303 Dna sequence encoding, proteins and peptides
10/20/1998US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/15/1998WO1998045712A2 20 human secreted proteins
10/15/1998WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998WO1998045441A1 Human gtp binding protein
10/15/1998WO1998045439A1 Human tumor-associated membrane protein
10/15/1998WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998WO1998045332A2 Humanized antibodies and methods for forming humanized antibodies
10/15/1998WO1998045331A2 Anti-vegf antibodies
10/15/1998WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998WO1998045322A2 Diagnosis method and reagents
10/15/1998WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998WO1998045301A1 Vinca alkaloid antimitotic halogenated derivatives
10/15/1998WO1998045288A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998WO1998045286A1 Prevention of breast cancer with selective estrogen receptor modulators
10/15/1998WO1998045285A1 Somatostatin agonists
10/15/1998WO1998045257A1 Thio derivatives as naaladase inhibitors
10/15/1998WO1998045256A1 Hydroxamic acid derivatives
10/15/1998WO1998045255A1 Calcilytic compounds
10/15/1998WO1998045253A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998WO1998044925A1 Calcilytic compounds
10/15/1998WO1998044922A1 Somatostatin agonists
10/15/1998WO1998044921A1 Somatostatin agonists
10/15/1998WO1998044919A1 Use of aminothiolester derivatives in pharmaceutics
10/15/1998WO1998044797A1 A method of treating cancer
10/15/1998WO1998044788A2 Animal model for evaluation of vaccines
10/15/1998WO1998035693A3 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
10/15/1998WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998WO1998029105A3 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations
10/15/1998WO1998024421A3 Use of dextrin sulphate for the treatment of highly vascular tumours
10/15/1998WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998DE19715504A1 PMMA-Membranen mit Polyethylenglykol-gekoppelten Wirksubstanzen PMMA membranes with polyethylene glycol-coupled active substances
10/15/1998DE19715149A1 Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft Cancer therapy and diagnosis for the characterization of cancer cells with individual property
10/15/1998CA2665949A1 Vinca alkaloid antimitotic halogenated derivatives
10/15/1998CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998CA2287293A1 Somatostatin agonists
10/15/1998CA2287084A1 Diagnosis method and reagents
10/15/1998CA2286860A1 Radioisotope concentrator methods and compositions
10/15/1998CA2286454A1 Calcilytic compounds
10/15/1998CA2286390A1 Human tumor-associated membrane protein
10/15/1998CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998CA2286303A1 20 human secreted proteins
10/15/1998CA2286283A1 Human gtp binding protein
10/15/1998CA2286239A1 A method of treating cancer
10/15/1998CA2286207A1 Prevention of breast cancer with selective estrogen receptor modulators
10/15/1998CA2286204A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998CA2286186A1 Activated iododerivatives for the treatment of cancer and aids
10/15/1998CA2285906A1 Hydroxamic acid derivatives
10/15/1998CA2285604A1 Somatostatin agonists
10/15/1998CA2285556A1 Calcilytic compounds
10/15/1998CA2285223A1 Somatostatin agonists
10/15/1998CA2285020A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870764A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/14/1998EP0870038A1 INTERLEUKIN-1$g(b) CONVERTING ENZYME LIKE CYSTEINE PROTEASE
10/14/1998EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998EP0870019A2 Cell activation process and reagents therefor
10/14/1998EP0870018A1 Antitumour vector constructs and methods
10/14/1998EP0869975A1 Assay for and uses of peptide hormone receptor ligands
10/14/1998EP0869970A1 Endothelial cell proliferation inhibitor and method of use
10/14/1998EP0869967A2 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
10/14/1998EP0869955A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/14/1998EP0869947A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/14/1998EP0869818A1 Cytotoxic agents
10/14/1998EP0869809A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
10/14/1998EP0869808A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
10/14/1998EP0869805A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications
10/14/1998EP0869803A1 Allogeneic paracrine cytokine tumor vaccines
10/14/1998EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998EP0869798A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
10/14/1998EP0869787A1 Vitronectin receptor antagonists
10/14/1998EP0869786A1 Pharmaceutical compounds
10/14/1998EP0869782A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
10/14/1998EP0855911A4 Namenamicin, an enediyne antitumor antibiotic from the marine ascidian polysyncraton lithostrotum
10/14/1998EP0841912A4 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
10/14/1998EP0769932B1 Implanted device containing tumor cells for the treatment of cancer
10/14/1998EP0695293B1 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents
10/14/1998EP0628054B1 Car receptors and related molecules and methods
1 ... 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 ... 2211